Summary: * MetLife's stock has significantly underperformed the broader market in 2020. * The company's recent operating results (and management commentary) prove that the investment thesis remains intact. Moreover, MetLife has a real capital return story to tell. * MetLife is well-positioned for 2021 and beyond. As such, we plan to stay long the stock. MetLife's ($MET) stock price has recovered lately but shares are still significantly underperforming the broader market on a